| 000 | 01652 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514200225.0 | ||
| 264 | 0 | _c20050408 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000079135 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSingh, Vijay Pal | |
| 245 | 0 | 0 |
_aAggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats. _h[electronic resource] |
| 260 |
_bPharmacology _cOct 2004 |
||
| 300 |
_a77-84 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDextran Sulfate |
| 650 | 0 | 4 |
_aDinoprostone _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Contraction _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aPeroxidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xmetabolism |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 700 | 1 | _aPatil, Chandrashekhar S | |
| 700 | 1 | _aJain, Naveen K | |
| 700 | 1 | _aKulkarni, Shrinivas K | |
| 773 | 0 |
_tPharmacology _gvol. 72 _gno. 2 _gp. 77-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000079135 _zAvailable from publisher's website |
| 999 |
_c15029473 _d15029473 |
||